Cargando…
The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea
BACKGROUND: The number of clinical trials conducted in Korea continues to increase and an increasing proportion focus on severe and rare incurable diseases. After the start of the severe acute respiratory syndrome, coronavirus disease 2019 (COVID-19), Korea Centers for Disease Control and Prevention...
Autores principales: | Jeon, JuYeun, Kim, Hyeikyoung, Yu, Kyung-Sang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490200/ https://www.ncbi.nlm.nih.gov/pubmed/32924344 http://dx.doi.org/10.3346/jkms.2020.35.e329 |
Ejemplares similares
-
A meta-analysis: efficacy and safety of anti-epileptic drugs prescribed in Korea as monotherapy and adjunctive treatment for patients with focal epilepsy
por: Jeon, JuYeun, et al.
Publicado: (2021) -
Estimating the Effectiveness of Non-Pharmaceutical Interventions on COVID-19 Control in Korea
por: Min, Kyung-Duk, et al.
Publicado: (2020) -
The Changes in Trends of Lower Gastrointestinal Endoscopy Conducted in Children and Adolescents after the COVID-19 Outbreak in Korea
por: Lee, Sang Woo, et al.
Publicado: (2022) -
The necessary conduct: Exploratory multiregional clinical trials in East Asia
por: Jeon, Inseung, et al.
Publicado: (2021) -
Impact of the COVID-19 pandemic on the conduct of clinical trials: a quantitative analysis
por: Margas, Wojciech, et al.
Publicado: (2022)